BUY Rolex Rings Limited — Deven Mehata, IDBI Capital Markets and Securities
byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: 1–3 months25 Sept 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
66% returns in 6 months, small-cap stock Rolex Rings gets Buy rating: InCred sees 32% upside - Check share price target
NewsLivemint·2 Oct · 5d ago
2 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·2 Oct · 5d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Rolex Rings
- BUY — Arun Kumar Mantri11 Nov 2026 · ~2 weeks · target ₹250 · Active
- BUY — Kunal Saraogi8 Nov 2026 · ~2 weeks · target ₹240 · Active
- BUY — IDBI Capital6 Nov 2026 · ~1 year · target ₹241 · Active
- BUY — Rakesh Bansal6 Nov 2026 · ~1 year · target ₹250 · Active
- BUY — Jigar S Patel, Anand Rathi19 Oct 2026 · ~2 weeks · target ₹200 · Expired
More from Deven Mehata, IDBI Capital Markets and Securities
- BUY Balmer Lawrie & Company11 Nov 2026 · ~2 weeks · target ₹200 · Active
- BUY Waaree Energies11 Nov 2026 · ~2 weeks · target ₹2,750 · Active
- BUY Central Depository Services (India)9 Nov 2026 · ~2 weeks · target ₹1,420 · Target hit
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Onesource Specialty Pharma9 Nov 2026 · ~2 weeks · target ₹1,765 · Active

